Mon, Jan 26, 2015, 8:29 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

BioCryst Pharmaceuticals, Inc. Message Board

huskys4u2 414 posts  |  Last Activity: 5 hours ago Member since: Jan 26, 2006
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Downgrade and Fast Track on Same Day

    by capcod3 5 hours ago
    huskys4u2 huskys4u2 5 hours ago Flag

    McClean Capital - check out their website ,it looks like it was made overnight. it's also a one man shop..

    this is what happens when hedgies are in a bind. call up a one man shop and see if he can scare up some shares. expect the bizarre out of wall street the next tree weeks until earnings...

  • because thats where the growth is…

    and it's about time our valuation gets to where it should be...

  • Reply to

    What is BCX7353? New drug?

    by copper_athlon 9 hours ago
    huskys4u2 huskys4u2 9 hours ago Flag

    looks like it…the hits just keep coming...

  • Reply to

    Husky has a Point and an Apology to the Board

    by me2yousee Jan 25, 2015 4:59 PM
    huskys4u2 huskys4u2 9 hours ago Flag

    "Down cycles NEVER end in less than 4 weeks and it has only went negative for about 1 1/2 weeks. The MACD ALWAYS goes down and flattens out with the old head fake and then it breaks down one more time."

    wrong again…you're batting 1000…

    "Now come on. How long you been in this?"

    long enough to know when it comes to biotech, technicals only work SOME of the time...

  • huskys4u2 huskys4u2 9 hours ago Flag

    "BioCryst is enrolling HAE patients in the OPuS-2 trial of BCX4161; a double-blind, randomized, placebo controlled trial conducted in the U.S. and certain EU countries, with the goal of demonstrating the efficacy and safety of BCX4161 treatment for 12 weeks in approximately 100 patients with HAE. BioCryst expects to report results from OPuS-2 by the end of 2015."

    cannonball! - line those shot glasses up for the shorts…who can't read.

    actually, i'm in the southwest, played 18 yesterday- it was beautiful…thanks.

  • The designation awarded by the U.S. Food and Drug Administration means the drug developer can move the drug called BCX4161 through the development process faster, ideally bringing the drug to market sooner, meaning BioCryst can make money faster.

    and make the shorts squeal louder...

  • huskys4u2 huskys4u2 10 hours ago Flag

    recruiting in 13 states, a 12 week study = guts on a stick.

  • huskys4u2 huskys4u2 10 hours ago Flag

    "The Fast Track designation process of the FDA is designed to facilitate the development and expedite the review and approval of drugs intended to treat serious or life threatening conditions and that address unmet medical needs. A drug that receives Fast Track designation is usually eligible for more frequent written communication and meetings with the FDA to discuss the drug's development plan and the collection of appropriate data supporting drug approval. Priority Review and Rolling Review may be granted, if relevant criteria are met. Rolling Review allows a drug company to submit completed sections of its New Drug Application (NDA) for review by FDA on an ongoing basis, rather than wait until the entire NDA is completed and then reviewed."

    approval by EOY…or sooner...

  • Reply to

    The more things change...

    by straight01shot Jan 25, 2015 3:52 PM
    huskys4u2 huskys4u2 Jan 25, 2015 6:53 PM Flag

    There is nothing wrong with your monitor. Do not attempt to adjust the picture.

    You are about to participate in a great adventure. You are about to experience the awe and mystery which reaches from the inner mind to – The Outer Limits...

  • Reply to

    hammer time...

    by huskys4u2 Jan 22, 2015 5:31 PM
    huskys4u2 huskys4u2 Jan 25, 2015 12:07 PM Flag

    "You quoted posts out of the FDA section that I posted so you obviously read it. If it is .... unlikely to be used in hospitals because of the timeline for admissions and the diarrhea."

    "And if it is unlikely to be used from a Doctors office because of the warning to monitor"

    now wait a minute. first hospitals are going to deny medications so they can stay longer, now they won't because of having to monitor patients after administration?

    man, you must be hurting'...

    can't help but notice you took down the post about lawyers, can you refresh us please?maybe i missed it.

    "If insurance coverage isn't obtained, neither hospitals or doctors are going to administer it."

    may i direct you to the BCRX website - (it's under reimbursements)? it's right there…

    Setting of Care
    Medicare-Yes
    Medicaid-Varies
    Private Payers-Varies

    i'll guess what the CT is for, it's a document for a business transaction between 2 companies (for something like supplies) where it's important that it remain confidential…

    dude, your not going to fool anybody here...

  • Last updated: January 24. 2015 2:26PM

    The flu virus continues to spread across the U.S., with the Centers for Disease Control and Prevention (CDC) closely tracking the number of confirmed cases and urging stringent precautions to minimize its impact. Medical Center of Southeastern Oklahoma continues to see flu-symptomatic patients in the emergency room and numerous patients have been admitted for treatment of flu-related complications.

    If you suspect you have the flu virus, the CDC recommends seeking care from your doctor or an urgent care clinic, where you can be tested and receive a prescription for antiviral medication to minimize the intensity and duration of your symptoms. These medications work best when taken within 48 hours of becoming ill, but can still be beneficial when given later in the course of illness.

    When you or someone for whom you’re caring experiences any of the following symptoms – the CDC recommends seeking help from the closest emergency department:

    it's still not enough. gotta go mainstream, do TV spots...

  • Reply to

    hammer time...

    by huskys4u2 Jan 22, 2015 5:31 PM
    huskys4u2 huskys4u2 Jan 24, 2015 12:40 PM Flag

    "Get my credibility back?" NO.

    "Not to rain on your party, but if you look at the Sept decline, you will see at least 3 hammers in that down swing as pretty as the last one. " - really? i'm not seeing it. the other thing about these reversals are that they have to be confirmed by several positive days afterward. and yes, the index has helped. if the market drops 500 points we're going down too, no doubt about it…

    "Now Husk got all bent out of shape on another thread because I had a discussion with somebody that was anti inhibitors in general."

    tell us the story again about how a hospital intentionally keeps drugs from patients in to run up a bill…please name names.

    if you think P isn't going to be used because "getting treated and driving home and having an accident that kills somebody" - please read the insert for tamiflu.

    "The point I was trying to make with Husk was that people think as they do." yep. and you don't need to be from texas to know the smell of BS…

    "Today it's not arrows but something worse .... lawyers. And while gov't employees are free to advise what they want, doctors can't." - doctors ARE NOT LIABLE FOR A FDA APPROVED DRUG.

    " but BCRX essentially told us that it wouldn't sell either" - really? can you reference that please?

    look, i know this drug isn't going to be a great blockbuster generating billions. but it is go enough to turn a cash burn company to profitable one.

    tell us the story again about how we secretly sold the rights to P in that CT order…that's a good one…

    better yet, tell me you- as harry carey used to say - were "exhausted" when you wrote those posts…

    ""Get my credibility back?" nope, not a chance.

  • Reply to

    hammer time...

    by huskys4u2 Jan 22, 2015 5:31 PM
    huskys4u2 huskys4u2 Jan 23, 2015 3:56 PM Flag

    finviz has the best charts, as you can see the 2 hammers in the best format. chartists will see those 2 reversal's and tell you that this is one strong buy signal...

  • Reply to

    hammer time...

    by huskys4u2 Jan 22, 2015 5:31 PM
    huskys4u2 huskys4u2 Jan 23, 2015 3:36 PM Flag

    the higher she goes, the stronger the hammer…

    all this when the MACD was bearish…hmmmm...

  • Covered Call Alert: BIOCRYST PHARMACEUTICALS $BCRX returning up to 44.51% through 19-Jun-2015

    i guess those 11 million short shares gotta cover sooner or later...

  • Reply to

    cheer up fellas...

    by huskys4u2 Jan 14, 2015 1:59 PM
    huskys4u2 huskys4u2 Jan 23, 2015 2:28 PM Flag

    "What happened ? ? Did you loose your house ? ?"

    nope. it never hit 10 and i was waiting, and i'll be waiting again... if this finger finder works again, i doubt we'll ever see 10 again. we'll find out in the next few trading days, if she holds up...

  • Reply to

    hammer time...

    by huskys4u2 Jan 22, 2015 5:31 PM
    huskys4u2 huskys4u2 Jan 23, 2015 11:28 AM Flag

    hey fellas - remember "the single hammer finger finder"? just last month? well here we go again.

    the finger finder hammer is in…

    Of all candlestick patterns, single bar hammers and dojis provide the most versatile immediate feedback. Western technical analysis rarely offers such dependable single bar signals.

    Hundreds of stocks printed long-legged dojis and hammers during a dramatic reversal day. DELL didn't return to test its low for over 2 years after this death-defying leap. Pay close attention to gap support or resistance created by the bar following the candle event.

    Dojis and hammers predict immediate reversals within the time frames they are created. Their significance directly relates to their position within the overall chart pattern. When appearing on high volume near significant highs or lows, they may represent price extremes signifying an important change in trend. If printed within an ongoing congestion pattern, they often reflect market makers or specialists "cleaning out" stops in one direction so they can move the market in the opposite direction.

    have a nice day fellas...

  • Disease outbreaks high on Davos agenda after Ebola

    DAVOS, Switzerland, Jan 23 (Reuters) - The worst-ever Ebola epidemic is waning, but after ravaging three West African nations and spreading fear from Dallas to Madrid, it has hammered home the message that the world needs a better detective system for emerging diseases.

    Risks posed by pandemic threats such as deadly strains of flu and drug-resistant superbugs have shot up the agenda of global security issues at this year's World Economic Forum in Davos as politicians and scientists grapple with the lessons from an Ebola outbreak that has killed more than 8,600 people.

    One thing is certain: more epidemics are coming and dense urban living, coupled with modern travel, will accelerate future infectious disease outbreaks.

  • AstraZeneca announced today in a statement that EMA had accepted the company’s regulatory filing for lesinurad, a selective uric acid re-absorption inhibitor,for use in combination with existing medicines in gout patients when additional therapy is warranted. Gout is a type of inflammatory arthritis caused by the build-up of too much uric acid in the body.

    The marketing authorisation application for lesinurad comes after last year AstraZeneca posted positive top-line results from three late-stage trials investigating the potential of the compound. (AstraZeneca share price: Drugmaker posts good gout drug results) The company, however, noted at the time that the studies had pointed to side effects including upper respiratory tract infection, back pain and kidney stones and added that a full assessment of the safety and tolerability findings of all three studies was ongoing.

    and if it gets rejected?

  • huskys4u2 by huskys4u2 Jan 22, 2015 5:31 PM Flag

    total reversal...

BCRX
11.33+0.340(+3.09%)Jan 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Microsoft Corporation
NASDAQMon, Jan 26, 2015 4:00 PM EST
Box, Inc.
NYSEMon, Jan 26, 2015 4:01 PM EST